Basit öğe kaydını göster

dc.contributor.authorZeyneloglu, Hulusi Bulent
dc.contributor.authorTohma, Yusuf Aytac
dc.contributor.authorGunakan, Emre
dc.date.accessioned2022-09-12T11:10:06Z
dc.date.available2022-09-12T11:10:06Z
dc.date.issued2021
dc.identifier.issn0951-3590en_US
dc.identifier.urihttp://hdl.handle.net/11727/7677
dc.description.abstractObjective In this study, we aimed to compare the efficacy of luteal phase stimulation (LPS) and follicular phase stimulation (FPS) in two separate menstrual cycles (2-5 months intervals) of the same patient, utilizing LPS with dydrogesteron only. Methods This retrospective case control study was conducted with patients with diminished ovarian reserve (DOR) (Group 1) and infertile patients with Anti-Mullerian hormone >1.2 ng/mL (Group 2) undergoing two ovarian stimulations (FPS and LPS with dydrogesteron only) and two oocyte retrievals in two separate menstrual cycles (2-5 months intervals) in the Division of Reproductive Endocrinology and Infertility of Baskent University, Ankara, between April 2019 and December 2019. Results In group 1, the number of frozen embryos was significantly higher in LPS when compared to FPS; 1.71 vs. 0.54, (p < .001), respectively. In group 2, the number of frozen embryos was higher in LPS when compared to FPS (0.8 vs. 0.4) however the difference did not reach a statistical significance (p: 0.157). Conclusion LPS may be beneficial especially in the patients with diminished ovarian reserve with follicular asynchronization in the menstrual onset. In addition, it should be kept in mind that dydrogesterone only may be used instead of gonadotropin-releasing hormone antagonist to prevent possible luteinizing hormone rise in LPS.en_US
dc.language.isoengen_US
dc.relation.isversionof10.1080/09513590.2021.1922885en_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectDiminished ovarian reserveen_US
dc.subjectluteal phase stimulationen_US
dc.subjectfollicular phase stimulationen_US
dc.titleDydrogesterone primed luteal phase stimulation may be better than follicular phase stimulation in patients with diminished ovarian reserveen_US
dc.typearticleen_US
dc.relation.journalGYNECOLOGICAL ENDOCRINOLOGYen_US
dc.identifier.volume37en_US
dc.identifier.issue11en_US
dc.identifier.startpage1000en_US
dc.identifier.endpage1002en_US
dc.identifier.wos000646911200001en_US
dc.identifier.scopus2-s2.0-85105377384en_US
dc.contributor.pubmedID33944650en_US
dc.contributor.orcID0000-0002-0289-2642en_US
dc.contributor.orcID0000-0001-9418-4733en_US
dc.contributor.orcID0000-0001-8854-8190en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergien_US
dc.contributor.researcherIDB-6487-2009en_US
dc.contributor.researcherIDAAE-6482-2021en_US
dc.contributor.researcherIDABI-1707-2020en_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster